Is It Still Worth Buying GSK After a 46% Rally in Shares This Year
GSK has seen a steep run in its stock, prompting questions about whether the rally still offers upside. This article ...
Indices adjust divisors to reflect corporate actions and maintain continuity. This note covers the main reasons these changes occur.
28,369 articlesGSK has seen a steep run in its stock, prompting questions about whether the rally still offers upside. This article ...
Two decades after the Iraq War, Iran's footprint in Iraqi politics and security is shaping energy markets and investo...
A Biel note argues that biel: salesforce’s transaction data creates a durable moat for Salesforce, tying revenue to a...
Oil prices stay elevated as the u.s. energy chief signals the Iran conflict may extend for weeks. Officials say short...
Arizona robotics builder FrameTec is expanding its automated framing operation to slash build-cycle times and reduce ...
Ford’s 5% yield draws income investors, but the path to EV profitability and a big impairment bill raise questions ab...
Nvidia faces strong AI-driven demand and a robust roadmap that could push long-term targets higher. Analysts weigh ne...
Vail Resorts is signaling a strategic pivot away from the iconic $1,000 Epic Pass as season results lag and weather c...
ZachXBT has renewed scrutiny of Tokenlon, a smaller decentralized exchange, alleging illicit funds flow. Tokenlon reb...
Optimum (OPTU) is reshaping its strategy in 2026. This original analysis dives into the Q1 results, margins, and capi...
Cardano has weathered wild crypto cycles before. This guide lays out credible scenarios for 2030, explains what could...
Birkenstock's 2026 earnings reveal how the brand is balancing direct-to-consumer growth with wholesale pressures. Thi...